Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks. Satisfaction was assessed after 8 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Enrollment
48
They took the Mulberry leaf extract capsule (DNJ 12mg) 3 times/day for 8 weeks.
They took the sample 3 times/day for 8 weeks.
Chulalongkorn
Bangkok, Thailand
RECRUITINGAspartate transaminase (AST) level
Aspartate transaminase (AST) is in normal range.
Time frame: 8 weeks
Alanine aminotransferase (ALT) level
Alanine aminotransferase (ALT) is in normal range.
Time frame: 8 weeks
Blood urea nitrogel level
Blood urea nitrogen (BUN) is in normal range.
Time frame: 8 weeks
Creatinine level
Creatinine is in normal range.
Time frame: 8 weeks
Complete blood counts
Complete blood counts are in normal range.
Time frame: 8 weeks
Adverse events
Adverse events are observed.
Time frame: 8 weeks
Alkaline phosphatase (ALP) level
Alkaline phosphatase (ALP) is in normal range.
Time frame: 8 weeks
Blood glucose level
Fasting plasma glucose and HbA1c are in normal range.
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.